Indication

Prevention of relapse to opioid dependence

Prevention of relapse to opioid dependence refers to a clinical maintenance phase in individuals with opioid use disorder who have successfully undergone detoxification and achieved medically supervised opioid abstinence. Read more about Prevention of relapse to opioid dependence

56 drugs 47 manufacturers

Advertisement

Drugs that treat it

Common Prevention of relapse to opioid dependence therapies.

Showing 46–54 of 56 drugs

NALTREXONE HCL

OPIOID ANTAGONISTS·ALCOHOL USE DISORDER·+1
Avet Pharmaceuticals

BUPRENORPHINE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE·PREVENTION OF RELAPSE TO OPIOID DEPENDENCE·+1
A-S MEDICATION

NALTREXONE HCL

OPIOID ANTAGONISTS·ALCOHOL USE DISORDER·+1
APHENA PHARMA S

NALTREXONE HCL

OPIOID ANTAGONISTS·ALCOHOL USE DISORDER·+1
ELITE LABORATOR

BUPRENORPHINE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE·PREVENTION OF RELAPSE TO OPIOID DEPENDENCE·+1
REMEDYREPACK, I

NALTREXONE HCL

OPIOID ANTAGONISTS·ALCOHOL USE DISORDER·+1
REMEDYREPACK, I

BUPRENORPHINE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE·PREVENTION OF RELAPSE TO OPIOID DEPENDENCE·+1
SpecGx

NALTREXONE HCL

OPIOID ANTAGONISTS·ALCOHOL USE DISORDER·+1
APHENA PHARMA S
Filter & compare in the drug finder →Opens the drug finder with Prevention of relapse to opioid dependence preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Prevention of relapse to opioid dependence.

Prevention of relapse to opioid dependence refers to a clinical maintenance phase in individuals with opioid use disorder who have successfully undergone detoxification and achieved medically supervised opioid abstinence.

This post-withdrawal state affects the central nervous system, where persistent neuroadaptations in brain reward and stress pathways leave individuals vulnerable to intense cravings, conditioned environmental cues, and recurrent nonmedical opioid consumption.

Clinically, it targets the critical vulnerability period following detoxification when loss of pharmacologic tolerance dramatically elevates the risk of fatal overdose upon any resumption of opioid use.

Interventions for this indication focus on stabilizing neurobiological function and preventing the re-establishment of physical dependence and compulsive use patterns.

Personalize your experience

Follow Prevention of relapse to opioid dependence and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it